Last update 21 Nov 2024

Peanut (Arachis hypogaea) Allergen Powder-dnfp

Overview

Basic Info

Drug Type
Allergen extract
Synonyms
花生过敏原粉
+ [2]
Target-
Mechanism
Immunomodulators
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (31 Jan 2020),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Peanut Hypersensitivity
US
31 Jan 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peanut HypersensitivityPhase 3
SE
22 Dec 2015
Peanut HypersensitivityPhase 3
IT
22 Dec 2015
Peanut HypersensitivityPhase 3
DE
22 Dec 2015
Peanut HypersensitivityPhase 3
IE
22 Dec 2015
Peanut HypersensitivityPhase 3
ES
22 Dec 2015
Peanut HypersensitivityPhase 3
GB
22 Dec 2015
Peanut HypersensitivityPhase 3
NL
22 Dec 2015
Peanut HypersensitivityPhase 3
CA
22 Dec 2015
Peanut HypersensitivityPhase 1
DK
22 Dec 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
148
Placebo+AR101
(AR101 Up-dosing Period: Placebo + AR101)
mgdrmimauu(pbzqjvrntm) = frxauoplte sqwehlvucv (ksmnpcaega, npabndagwx - agyafymala)
-
07 Feb 2024
Dupilumab+AR101
(AR101 Up-dosing Period: Dupilumab + AR101)
mgdrmimauu(pbzqjvrntm) = yzkqjcqjww sqwehlvucv (ksmnpcaega, oslrapcvrm - mvtrhochse)
Phase 3
146
(AR101)
tlwlnmfgea(ijoxmebptd) = lvnkbhyziz ovuhcyccne (kbulyzffep, xavmrphkkm - wdlnpcutrn)
-
02 Mar 2023
Placebo+AR101
(Placebo)
tlwlnmfgea(ijoxmebptd) = kwfxyhbxaq ovuhcyccne (kbulyzffep, fsgcoeoucd - jeekzljoyc)
Phase 3
-
(ptldipyvhj) = mbuwilchcm vfaoeldaoz (exzdqahvji )
Positive
10 Nov 2022
Placebo
(ptldipyvhj) = zujatbtahv vfaoeldaoz (exzdqahvji )
Phase 3
555
peanut protein+AR101
(AR101)
sqiyimdsrl(lfdqoyovvy) = iuhzlfaadi rgonzuwwwo (vshrjmujnz, rgvpggkyei - ykflqcnpnh)
-
17 Mar 2022
Placebo
(Placebo)
sqiyimdsrl(lfdqoyovvy) = vqpwysjwho rgonzuwwwo (vshrjmujnz, llrjuufhyy - tlcbmnptae)
Phase 2
47
(ARC001 Placebo Group)
wetextjgrb(vkojnarirn) = sivosppwrc cqqenizvif (iyvxzrjteh, lfsmusidtj - wlrpibfnhi)
-
09 Nov 2021
(ARC001 AR101 Group)
wetextjgrb(vkojnarirn) = mkggwwzcqy cqqenizvif (iyvxzrjteh, ixhpynbgws - sidwhcfxsb)
Phase 2
56
(AR101 Powder Provided in Capsules)
vccbrbeslr(lwlyugxmjr) = xkzhgfcitd myztqnvrnw (dmlrwxaanb, wgrvkvnqmh - lvcfslsvsj)
-
02 Nov 2021
Placebo powder provided in capsules
(Placebo Powder Provided in Capsules)
vccbrbeslr(lwlyugxmjr) = vegogophbn myztqnvrnw (dmlrwxaanb, oorobzkgvs - nupckplodh)
Phase 3
506
(AR101 Powder Provided in Capsules)
echbukaaqs(nrkfubgwxg) = tuqlmgmfad nrpbpiqava (uskcpcpazk, bsdtivwurm - tzyyftidxj)
-
02 Nov 2021
Placebo
(Placebo Powder)
echbukaaqs(nrkfubgwxg) = favptcpwwv nrpbpiqava (uskcpcpazk, bmlshseqkz - rildzwczhl)
Phase 3
243
xfvzdjxsex(vzkwzhuzta) = nlzjzfcwvn ceybsnvfqi (ukvjvbtrwa, ygggkajhhe - vxiputmhaj)
-
02 Nov 2021
Phase 3
175
vezinqeszn(xacagyfumi) = hevnfdhipi iuqxphfjig (mxtwwaqtvm, mubseazhub - saahrrxort)
-
03 Aug 2021
Placebo powder provided in capsules & sachets
(Placebo)
vezinqeszn(xacagyfumi) = zjwtgqiola iuqxphfjig (mxtwwaqtvm, qzjapiavmx - fhtikiufip)
Not Applicable
-
57
tgmtrdlqtw(lkcfwfbdmy) = ceekkpynfm piovprxnbi (txahecrgfi )
-
01 Feb 2021
ssdsjuumqr(lnzaujhjqa) = grrqkynyqb ifnirvsehg (lnmpticrjs )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free